Report cover image

Asia Pacific Self-injections Market

Publisher Data Bridge Market Research
Published Sep 01, 2024
Length 353 Pages
SKU # DAABD19472228

Description

Asia Pacific Self-injections Market


Asia-Pacific self-injection market is expected to reach USD 19.43 billion by 2031 from USD 8.51 billion in 2023, growing with a CAGR of 11.1% in the forecast period of 2024 to 2031.

Asia-Pacific Self-injections Market, By Product Type (Self-Injection Devices and Self-Injection Formulation), Dosage Form (Single Dose and Multi-Dose), Route of Administration (Subcutaneous, Intra muscular, and Others), Application (Autoimmune Diseases, Pain Management, Emergency Drugs, Oncology, Hormonal Disorders, and Others), Age Group (Adult, Geriatric, and Pediatric), Gender (Male and Female), Distribution Channel (Direct Tender, Hospital Pharmacy, Online Pharmacy, and Others), Country (China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Indonesia, Australia, Philippines, New Zealand, Taiwan, Vietnam, and Rest of Asia-Pacific) – Industry Trends and Forecast to 2031
Overview of Asia Pacific Self-Injections Market Dynamics:
Driver
• Rising prevalence of chronic disease
Restraint
• High cost of self injectors
Opportunity
• Government initiatives to self-injections
Market Players:
The key market players operating in the Asia-Pacific self-injection market are listed below:
• Novo Nordisk A/S
• Johnson & Johnson Services, Inc.
• Biogen
• Amgen Inc.
• Sanofi
• AbbVie Inc.
• YPSOMED
• BD
• AstraZeneca
• AptarGroup, Inc.
• Bayer AG
• Bausch Health Companies Inc.
• Boehringer Ingelheim International GmBH
• F. Hoffmann-La Roche Ltd
• GSK plc
• Gerresheimer AG
• Haselmeier
• Ipsen Biopharmaceuticals, Inc.
• Lilly
• Midas Pharma GmBH
• Merck & Co., Inc.
• Novartis AG
• OVAL MEDICAL TECHNOLOGIES LTD. (SMC LIMITED)
• Pfizer Inc.
• Philips-Medisize
• PharmaJet
• Recipharm AB
• SCHOTT PHARMA
• SHL Medical AG
• Société Industrielle de Sonceboz SA
• Terumo Corporation
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals Industries Ltd.
• UCB Pharma
• West Pharmaceutical Services

Table of Contents

353 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-pacific Self-injections Market
1.4 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Therapeutics Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market Application Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insight
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Customizations
5 Asia-pacific Self-injections Market: Regulations
5.1 Regulatory Authorities In The Asia-pacific Region
5.1.1 Australia
5.1.2 China
5.1.3 India
5.2 Regulatory Submissions
5.2.1 Pre-submission Activities
5.2.2 Development Of Technical Documentation
5.3 Clinical Evaluation
5.4 Regulatory Submission Preparation
5.5 Submission To Regulatory Authority
5.6 Review And Evaluation By Regulatory Authority
5.7 Approval And Market Authorization
5.8 Post-market Surveillance
5.9 Renewal And Compliance
5.10 Asean Medical Device Directive (Amdd)
5.11 Adoption Of Asia-pacific Standards (Iso And Iec)
5.12 Collaboration Via Apec Regulatory Harmonization Steering Committee
5.13 Clinical Data Harmonization
5.14 Common Technical Document (Ctd) Format
5.15 Post-market Surveillance And Reporting Harmonization
5.16 Mutual Recognition Agreements (Mras)
5.17 Training And Capacity Building Initiatives
5.18 North America Regulatory Scenario
5.19 Medical Device Classification
5.20 Regulatory Submissions
5.21 Europe Regulatory Scenario
5.22 Regulatory Submissions
5.23 Middle East And Africa Regulatory Scenario
5.24 South America Regulatory Scenario
5.25 International Harmonization
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Chronic Disease
6.1.2 Technological Advancement In Self Injections
6.1.3 Increase In Patient Autonomy
6.1.4 Rise In Mobile Health Applications
6.2 Restraints
6.2.1 High Cost Of Self Injectors
6.2.2 Regulatory Hurdles And Need For Proper Training For Self-injection Devices
6.3 Opportunities
6.3.1 Government Initiatives To Self-injections
6.3.2 Increased Research And Development For Self-injection
6.3.3 Growing Demand For Biologics And Personalized Medicine
6.4 Challenges
6.4.1 Patient Reluctance Towards Needles
6.4.2 Environmental Concerns With Self-injections
7 Asia-pacific Self-injections Market, By Product Type
7.1 Overview
7.2 Self-injection Devices
7.3 Self-injection Formulation
8 Asia-pacific Self-injections Market, By Dosage Form
8.1 Overview
8.2 Single Dose
8.3 Multi-dose
9 Asia-pacific Self-injections Market, By Route Of Administration
9.1 Overview
9.2 Subcutaneous
9.3 Intra Muscular
9.4 Others
10 Asia-pacific Self-injections Market, By Application
10.1 Overview
10.2 Autoimmune Diseases
10.3 Pain Management
10.4 Emergency Drugs
10.5 Oncology
10.6 Hormonal Disorders
10.7 Others
11 Asia-pacific Self-injections Market, By Age Group
11.1 Overview
11.2 Adult
11.3 Geriatric
11.4 Pediatric
12 Asia-pacific Self-injections Market, By Gender
12.1 Overview
12.2 Male
12.3 Female
13 Asia-pacific Self-injections Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Hospital Pharmacy
13.4 Online Pharmacy
13.5 Others
14 Asia-pacific Self-injections Market, By Region
14.1 Asia-pacific
15 Asia-pacific Self-injections Market: Company Landscape
15.1 Company Share Analysis: Asia-pacific
16 Swot Analysis
17 Company Profiles
17.1 Novo Nordisk
17.1.1 Company Snapshot
17.1.2 Revenue
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.2 Johnson & Johnson Services, Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Biogen
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Product Portfolio
17.3.4 Recent Development
17.4 Amgen Inc.
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Sanofi
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Development
17.6 Abbvie Inc.
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Company Share Analysis
17.6.4 Product Portfolio
17.6.5 Recent Development
17.7 Ypsomed
17.7.1 Company Snapshot
17.7.2 Revenue Analysis
17.7.3 Product Portfolio
17.7.4 Recent Development
17.8 Bd
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Astrazeneca
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Developments
17.10 Aptargroup, Inc.
17.10.1 Company Snapshot
17.10.2 Revenue Analysis
17.10.3 Product Portfolio
17.10.4 Recent Developments
17.11 Bayer
17.11.1 Company Snapshot
17.11.2 Revenue
17.11.3 Product Portfolio
17.11.4 Recent Development
17.12 Bausch Health Companies Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.13 Boehringer Ingelheim International Gmbh
17.13.1 Company Snapshot
17.13.2 Revenue Analysis
17.13.3 Product Portfolio
17.13.4 Recent Developments
17.14 Credence Medsystems, Inc.
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.15 Dali Medical Devices
17.15.1 Company Sn.Apshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Enable Injections
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Developments
17.17 E3d Elcam Drug Delivery Devices
17.17.1 Company Snapshot
17.17.2 Product Portfolio
17.17.3 Recent Development
17.18 F. Hoffmann-la Roche Ltd
17.18.1 Company Snapshot
17.18.2 Revenue Analysis
17.18.3 Product Portfolio
17.18.4 Recent Development
17.19 Gsk Plc
17.19.1 Company Snapshot
17.19.2 Revenue Analysis
17.19.3 Product Portfolio
17.19.4 Recent Developments
17.20 Gerresheimer Ag
17.20.1 Company Snapshot
17.20.2 Revenue Analysis
17.20.3 Product Portfolio
17.20.4 Recent Developments
17.21 Haselmeier
17.21.1 Company Snapshot
17.21.2 Product Portfolio
17.21.3 Recent Development
17.22 Ipsen Biopharmaceuticals, Inc.
17.22.1 Company Snapshot
17.22.2 Revenue Analysis
17.22.3 Product Portfolio
17.22.4 Recent Development
17.23 Lilly
17.23.1 Company Snapshot
17.23.2 Revenue Analysis
17.23.3 Product Portfolio
17.23.4 Recent Development
17.24 Midas Pharma Gmbh
17.24.1 Company Snapshot
17.24.2 Product Portfolio
17.24.3 Recent Development
17.25 Merck & Co., Inc.,
17.25.1 Company Snapshot
17.25.2 Revenue Analysis
17.25.3 Product Portfolio
17.25.4 Recent Development
17.26 Novartis Ag
17.26.1 Company Snapshot
17.26.2 Revenue Analysis
17.26.3 Product Portfolio
17.26.4 Recent Developments
17.27 Nemera
17.27.1 Company Snapshot
17.27.2 Product Portfolio
17.27.3 Recent Development
17.28 Oval Medical Technologies Ltd. (Smc Limited)
17.28.1 Company Snapshot
17.28.2 Product Portfolio
17.28.3 Recent Development
17.29 Owen Mumford
17.29.1 Company Snapshot
17.29.2 Product Portfolio
17.29.3 Recent Development
17.30 Pfizer Inc.
17.30.1 Company Snapshot
17.30.2 Revenue Analysis
17.30.3 Product Portfolio
17.30.4 Recent Development
17.30.5 Recent Development
17.31 Philip Medsize
17.31.1 Company Snapshot
17.31.2 Product Portfolio
17.31.3 Recent Developments
17.32 Pharmajet.
17.32.1 Company Snapshot
17.32.2 Product Portfolio
17.32.3 Recent Development
17.33 Penjet
17.33.1 Company Snapshot
17.33.2 1.1.4 Product Portfolio
17.33.3 Recent Development
17.34 Recipharm Ab
17.34.1 Company Snapshot
17.34.2 Product Portfolio
17.34.3 Recent Developments
17.35 Schott Pharma
17.35.1 Company Snapshot
17.35.2 Product Portfolio
17.35.3 Recent Developments
17.36 Shl Medical Ag
17.36.1 Company Snapshot
17.36.2 Product Portfolio
17.36.3 Recent Development
17.37 Société Industrielle De Sonceboz Sa
17.37.1 Company Snapshot
17.37.2 Product Portfolio
17.37.3 Recent Development
17.38 Terumo Corporation
17.38.1 Company Snapshot
17.38.2 Revenue Analysis
17.38.3 Product Portfolio
17.38.4 Recent Development
17.39 Takeda Pharmaceutical Company Limited
17.39.1 Company Snapshot
17.39.2 Revenue Analysis
17.39.3 Product Portfolio
17.39.4 Recent Development
17.40 Teva Pharmaceuticals
17.40.1 Company Snapshot
17.40.2 Revenue
17.40.3 Product Portfolio
17.40.4 Recent Development
17.41 Ucb Pharma
17.41.1 Company Snapshot
17.41.2 Revenue
17.41.3 Product Portfolio
17.41.4 Recent Development
17.42 West Pharmaceutical Services
17.42.1 Company Snapshot
17.42.2 Revenue Analysis
17.42.3 Product Portfolio
17.42.4 Recent Developments
18 Questionnaire
19 Related Reports
Table 1 Asia-pacific Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 2 Asia-pacific Self-injection Devices In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 3 Asia-pacific Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 4 Asia-pacific Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 5 Asia-pacific Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 6 Asia-pacific Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 7 Asia-pacific Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 8 Asia-pacific Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 9 Asia-pacific Self-injection Formulation In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 10 Asia-pacific Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 11 Asia-pacific Single Dose In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 12 Asia-pacific Multi-dose In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 13 Asia-pacific Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 14 Asia-pacific Subcutaneous In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 15 Asia-pacific Intra Muscular In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 16 Asia-pacific Others In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 17 Asia-pacific Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 18 Asia-pacific Autoimmune Diseases In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 19 Asia-pacific Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 20 Asia-pacific Pain Management In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 21 Asia-pacific Emergency Drugs In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 22 Asia-pacific Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 23 Asia-pacific Oncology In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 24 Asia-pacific Hormonal Disorders In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 25 Asia-pacific Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 26 Asia-pacific Others In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 27 Asia-pacific Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 28 Asia-pacific Adult In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 29 Asia-pacific Geriatric In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 30 Asia-pacific Pediatric In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 31 Asia-pacific Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 32 Asia-pacific Male In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 33 Asia-pacific Female In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 34 Asia-pacific Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 35 Asia-pacific Direct Tender In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 36 Asia-pacific Hospital Pharmacy In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 37 Asia-pacific Online Pharmacy In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 38 Asia-pacific Others In Self-injections Market, By Region, 2022-2031 (Usd Million)
Table 39 Asia-pacific Self-injections Market, By Country, 2022-2031 (Usd Million)
Table 40 Asia-pacific Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 41 Asia-pacific Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 42 Asia-pacific Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 43 Asia-pacific Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 44 Asia-pacific Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 45 Asia-pacific Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 46 Asia-pacific Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 47 Asia-pacific Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 48 Asia-pacific Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 49 Asia-pacific Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 50 Asia-pacific Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 51 Asia-pacific Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 52 Asia-pacific Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 53 Asia-pacific Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 54 Asia-pacific Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 55 Asia-pacific Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 56 Asia-pacific Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 57 China Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 58 China Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 59 China Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 60 China Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 61 China Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 62 China Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 63 China Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 64 China Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 65 China Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 66 China Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 67 China Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 68 China Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 69 China Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 70 China Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 71 China Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 72 China Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 73 China Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 74 India Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 75 India Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 76 India Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 77 India Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 78 India Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 79 India Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 80 India Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 81 India Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 82 India Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 83 India Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 84 India Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 85 India Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 86 India Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 87 India Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 88 India Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 89 India Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 90 India Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 91 Japan Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 92 Japan Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 93 Japan Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 94 Japan Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 95 Japan Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 96 Japan Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 97 Japan Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 98 Japan Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 99 Japan Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 100 Japan Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 101 Japan Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 102 Japan Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 103 Japan Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 104 Japan Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 105 Japan Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 106 Japan Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 107 Japan Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 108 South Korea Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 109 South Korea Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 110 South Korea Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 111 South Korea Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 112 South Korea Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 113 South Korea Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 114 South Korea Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 115 South Korea Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 116 South Korea Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 117 South Korea Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 118 South Korea Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 119 South Korea Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 120 South Korea Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 121 South Korea Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 122 South Korea Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 123 South Korea Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 124 South Korea Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 125 Australia Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 126 Australia Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 127 Australia Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 128 Australia Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 129 Australia Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 130 Australia Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 131 Australia Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 132 Australia Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 133 Australia Self-injections Market, By Dosage Form, 2022-2031 (Usd Million)
Table 134 Australia Self-injections Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 135 Australia Self-injections Market, By Application, 2022-2031 (Usd Million)
Table 136 Australia Autoimmune Diseases In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 137 Australia Emergency Drugs In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 138 Australia Hormonal Disorders In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 139 Australia Self-injections Market, By Age Group, 2022-2031 (Usd Million)
Table 140 Australia Self-injections Market, By Gender, 2022-2031 (Usd Million)
Table 141 Australia Self-injections Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 142 Thailand Self-injections Market, By Product Type, 2022-2031 (Usd Million)
Table 143 Thailand Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 144 Thailand Self-injection Devices In Self-injections Market, By Type, 2022-2031 (Volume)
Table 145 Thailand Self-injection Devices In Self-injections Market, By Type, 2022-2031(Asp)
Table 146 Thailand Auto Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 147 Thailand Pen Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 148 Thailand Wearable Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)
Table 149 Thailand Needle-free Injectors In Self-injections Market, By Type, 2022-2031 (Usd Million)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us